The proposed Network brings together leading academic and industrial groups with diverse and complementary skills: the development of a variety of innovative biotechnology tools for the generation and exploitation of large genomic and man-made libraries, expertise in mechanistic enzymology and an unrivalled technology platform including phage display, in vitro compartmentalization, ribosome display, selective protein labelling and high-throughput screening that will be key to achieve the ambitious goals of this project. The project is a continuation of a highly successful framework 5 network. The partnership has now been extended by two successful SMEs at different stages of their development and one of Europe s premier medium-sized biotech companies that are keen to utilise and market the expected results of this collaborative effort.
Partner
 | Cambridge University, United Kingdom (Coordinator)
|
| ETH Lausanne, Switzerland
|
| Ben Gurion University of the Negev, Israel
|
| Université Catholique de Louvain, Belgium
|
| Universität Greifswald, Germany
|
| Covalys AG Basel, Switzerland
|
| Biotechnology Research and Information Network AG (BRAIN) Zwingenberg, Germany
|
| MedImmune Limited Cambridge, UK
|
| University of Groningen, Netherlands
|
| Institut de Science et d'Ingénierie Supramoléculaires (ISIS) Strasbourg, France
|
Project details
Contact: Prof. Bornscheuer
Start Date: 2008-10-15
End Date: 2012-10-14
Duration: 48 months
Project Reference: 215560
Project Funding: 2.4 million euro www.bio.cam.ac.uk/enefp
Source: Cordis
|
Katalyse
für Projekte
uni-greifswald.de
